Cargando…
Treatment and survival of rectal cancer patients over the age of 80 years: a EURECCA international comparison
BACKGROUND: The optimal treatment strategy for older rectal cancer patients remains unclear. The current study aimed to compare treatment and survival of rectal cancer patients aged 80+. METHODS: Patients of ≥80 years diagnosed with rectal cancer between 2001 and 2010 were included. Population-based...
Autores principales: | Claassen, Yvette H. M., Vermeer, Nina C. A., Iversen, Lene H., van Eycken, Elizabeth, Guren, Marianne G., Mroczkowski, Pawel, Martling, Anna, Codina Cazador, Antonio, Johansson, Robert, Vandendael, Tamara, Wibe, Arne, Moller, Bjorn, Lippert, Hans, Rutten, Harm J. T., Portielje, Johanneke E. A., Liefers, Gerrit J., Holman, Fabian A., van de Velde, Cornelis J. H., Bastiaannet, Esther |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6134121/ https://www.ncbi.nlm.nih.gov/pubmed/30057408 http://dx.doi.org/10.1038/s41416-018-0215-6 |
Ejemplares similares
-
Treatment and Survival of Elderly Patients with Stage I–II Pancreatic Cancer: A Report of the EURECCA Pancreas Consortium
por: Groen, Jesse V., et al.
Publicado: (2020) -
Variation in treatment and survival of older patients with non-metastatic breast cancer in five European countries: a population-based cohort study from the EURECCA Breast Cancer Group
por: Derks, Marloes G. M., et al.
Publicado: (2018) -
Improved survival of older patients with advanced breast cancer due to an increase in systemic treatments: a population-based study
por: de Glas, Nienke, et al.
Publicado: (2019) -
Efficacy and Adverse Events of Immunotherapy with Checkpoint Inhibitors in Older Patients with Cancer
por: van Holstein, Yara, et al.
Publicado: (2019) -
Prediction of Other-Cause Mortality in Older Patients with Breast Cancer Using Comorbidity
por: de Boer, Anna Z., et al.
Publicado: (2021)